ASCJ 9
Alternative Names: AJ-101; ASC-J9; Dimethyl curcuminLatest Information Update: 28 Mar 2025
At a glance
- Originator AndroScience Corporation
- Class Alkadienes; Antiacnes; Catechols; Small molecules
- Mechanism of Action Androgen receptor degradation enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase II Acne vulgaris
- No development reported Male pattern baldness; Wounds; X-linked bulbo-spinal atrophy
Most Recent Events
- 28 Mar 2025 No recent reports of development identified for preclinical development in Male-pattern-baldness in USA (Topical, Foam)
- 28 Mar 2025 No recent reports of development identified for preclinical development in Wounds in USA (Topical, Cream)
- 28 Mar 2025 No recent reports of development identified for preclinical development in X-linked-bulbo-spinal-atrophy in USA (PO)